Invention Grant
- Patent Title: Use of BRAF inhibitors for treating cutaneous reactions caused by treatment with a MEK inhibitor
-
Application No.: US16636974Application Date: 2018-08-08
-
Publication No.: US11458139B2Publication Date: 2022-10-04
- Inventor: Neal Rosen , Noa Shelach
- Applicant: MEMORIAL SLOAN KETTERING CANCER CENTER
- Applicant Address: US NY New York
- Assignee: MEMORIAL SLOAN KETTERING CANCER CENTER
- Current Assignee: MEMORIAL SLOAN KETTERING CANCER CENTER
- Current Assignee Address: US NY New York
- Agency: Foley & Lardner LLP
- International Application: PCT/US2018/045834 WO 20180808
- International Announcement: WO2019/032717 WO 20190214
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/4184 ; A61K31/428 ; A61K31/437 ; A61K31/4439 ; A61K31/4745 ; A61K31/506 ; A61K31/517
Abstract:
The present technology relates to compositions comprising BRAF inhibitors and uses thereof for treating and/or preventing a MEK inhibitor-associated cutaneous condition in a subject. Kits for use in practicing the methods are also provided.
Public/Granted literature
- US20200163967A1 USE OF BRAF INHIBITORS FOR TREATING CUTANEOUS REACTIONS CAUSED BY TREATMENT WITH A MEK INHIBITOR Public/Granted day:2020-05-28
Information query
IPC分类:
